Physician profile
David L Rubenstein
NPI 1477524007
$9,053.93
in general payments reported to CMS, 2019-2025
10 companies · $1,745 in 2025
The $1,745 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,065 · 2020: $372 · 2021: $1,451 · 2022: $1,638 · 2023: $277 · 2024: $506 · 2025: $1,745.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,764 · Food and Beverage: $764.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,764.34 |
| Food and Beverage | $763.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,410.71 | 2019-2025 | |
| Smith+Nephew, INC. | $1,681.12 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System, Healicoil, Accu-Pass |
| Paladin Technology Solutions | $1,658.53 | 2022-2025 | |
| Liberty Surgical INC. | $1,200.00 | 2021 | |
| Electronic Waveform Lab, INC. | $718.60 | 2019-2024 | |
| Trice Medical, INC. | $200.00 | 2019 | |
| Bioventus LLC | $82.52 | 2023 | Gelsyn-3 |
| Ferring Pharmaceuticals INC. | $56.92 | 2021-2023 | Euflexxa |
| Depuy Synthes Sales INC. | $27.07 | 2019 | |
| Avanos Medical | $18.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Rubenstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.